Abstract

A variety of tumors are potentially immunogenic but do not stimulate an effective anti-tumor immune response in vivo. Tumors may be capable of delivering antigen-specific signals to T cells, but may not deliver the costimulatory signals necessary for full activation of T cells. Expression of the costimulatory ligand B7 on melanoma cells was found to induce the rejection of a murine melanoma in vivo. This rejection was mediated by CD8 + T cells; CD4 + T cells were not required. These results suggest that B7 expression renders tumor cells capable of effective antigen presentation, leading to their eradication in vivo.

Keywords

Cytotoxic T cellMelanomaIn vivoCD8AntigenImmune systemCancer researchCD40TransfectionAntigen-presenting cellAntigen presentationImmunotherapyBiologyTumor antigenImmunologyT cellIn vitroCell culture

Affiliated Institutions

Related Publications

Publication Info

Year
1993
Type
article
Volume
259
Issue
5093
Pages
368-370
Citations
1140
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1140
OpenAlex

Cite This

Sarah E. Townsend, James P. Allison (1993). Tumor Rejection After Direct Costimulation of CD8 <sup>+</sup> T Cells by B7-Transfected Melanoma Cells. Science , 259 (5093) , 368-370. https://doi.org/10.1126/science.7678351

Identifiers

DOI
10.1126/science.7678351